Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Tezosentan in Pulmonary Arterial Hypertension

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01077297
Recruitment Status : Terminated (Due to slow recruitment, the study was prematurely discontinued)
First Posted : March 1, 2010
Last Update Posted : July 9, 2018
Sponsor:
Information provided by (Responsible Party):
Idorsia Pharmaceuticals Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : November 2010
Actual Study Completion Date : September 2011
Certification/Extension First Submitted : July 13, 2012